SAN DIEGO, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced that it will host a conference call and live webcast on Thursday, March 5, 2020 at 4:30 p.m. Eastern Time to report financial results for its fourth quarter and year ended December 31, 2019 and provide a business update.
|Conference Call & Webcast Details |
|Date:||Thursday, March 5, 2020|
|Time:||4:30 p.m. Eastern Time|
To access the call, participants should dial the applicable telephone number above at least 5 minutes prior to the start of the call. An archived version of the webcast will be available for replay in the Investors section of the Bionano website.
About Bionano Genomics
Bionano is a genome analysis company focused on structural variation detection. The Company’s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano data are available through adoption of Saphyr or through services offerings available around the world. For more information, visit www.bionanogenomics.com.
Erik Holmlin, Ph.D., CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
Investor Relations Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
+1 (617) 430-7577
The Ruth Group
+1 (508) 280-6592